Headlines
•Tesla Semi receives 370-unit order — PEP order adds to delivery pipeline
•CVS Health crushes Q1 estimates — stock skyrockets on Wednesday
•Arm reports record Q4 FY2026 results — cloud AI momentum accelerates, customer interest grows in new launch
•Recursion outlines runway into early 2028 while maintaining 2026 cash operating expenses under $390M (NASDAQ:RXRX)
•Marex signals margins in the mid-20s over 3 years as it targets Bermuda redomicile in 2H 2026 (NASDAQ:MRX)
•Guardian Pharmacy Services forecasts $123M-$127M adjusted EBITDA amid ira pricing reset (NYSE:GRDN)
•Nextdoor signals ~10% 2026 revenue growth while guiding Q2 revenue to $71M-$73M (NYSE:NXDR)